P095 - Patient (pt) reported pain and health-related quality of life (HRQoL) by genomic loss of heterozygosity (gLOH) status in men with metastatic castration-resistant prostate cancer (mCRPC) receiving talazoparib (TALA): TALAPRO-1
| Autor: | Saad, F., Stenzl, A., Mehra, N., Stirling, A., Renard, V., Machiels, J-P., Dorff, T., Maruzzo, M., Nazari, J., Bhattacharyya, H., Healy, C., Niyazov, A., Fizazi, K. |
|---|---|
| Zdroj: | In European Urology Open Science November 2022 45 Supplement 2:S172-S174 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|